- Report
- February 2024
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 61 Pages
From €3140EUR$3,450USD£2,692GBP
- Report
- February 2024
- 78 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- May 2022
- 324 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- May 2022
- 109 Pages
Africa, Middle East
From €1365EUR$1,500USD£1,170GBP
- Report
- June 2020
- 464 Pages
Global
From €4459EUR$4,900USD£3,823GBP
- Report
- November 2023
- 73 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- August 2024
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2022
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- August 2021
- 117 Pages
Global
From €3200EUR$3,767USD£2,839GBP
- Report
- November 2021
- 1165 Pages
Global
From €5461EUR$6,000USD£4,681GBP
The SNP Detection market within the context of Genomics is a rapidly growing field, as it is used to identify single nucleotide polymorphisms (SNPs) in a genome. SNPs are genetic variations that occur when a single nucleotide in the genome sequence is altered. SNP detection is used to identify genetic variations that may be associated with diseases, drug responses, and other traits. SNP detection is also used in the development of personalized medicine, as it can help to identify the best treatment for a particular individual.
SNP detection is used in a variety of applications, including gene expression analysis, genetic association studies, and population genetics. It is also used in the development of diagnostic tests and in the identification of genetic markers for disease.
Companies in the SNP Detection market include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories. Show Less Read more